Kumar, Bharath

Novo Nordisk (India)

1 paper on CoChatORCID 0009-0006-8691-6926

Most cited papers

Verified
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
Aroda, V. R., Jørgensen, N. B., Kumar, B., Lingvay, I., Laulund, A. S., Buse, J. B., & trial investigators (2025) · Diabetes Care
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 25

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free